BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 36031722)

  • 21. Applying a risk prediction model for bloodstream infection in a febrile, nonseverely neutropenic cohort of pediatric stem cell transplant patients.
    Jackson K; Anderson V; Zhao Z; Kitko CL; Connelly JA; Ho RH; Banerjee R; Dulek DE; Friedman DL; Esbenshade AJ
    Cancer; 2023 May; 129(10):1591-1601. PubMed ID: 36828805
    [TBL] [Abstract][Full Text] [Related]  

  • 22. External Validation of Six Pediatric Fever and Neutropenia Clinical Decision Rules.
    Haeusler GM; Thursky KA; Slavin MA; Mechinaud F; Babl FE; Bryant P; De Abreu Lourenco R; Phillips R
    Pediatr Infect Dis J; 2018 Apr; 37(4):329-335. PubMed ID: 28877157
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early discontinuation of antibiotics for febrile neutropenia versus continuation until neutropenia resolution in people with cancer.
    Stern A; Carrara E; Bitterman R; Yahav D; Leibovici L; Paul M
    Cochrane Database Syst Rev; 2019 Jan; 1(1):CD012184. PubMed ID: 30605229
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk-adapted approach for fever and neutropenia in paediatric cancer patients--a national multicentre study.
    Miedema KG; Tissing WJ; Abbink FC; Ball LM; Michiels EM; van Vliet MJ; de Vries WY; Kamps WA; Norbruis OF; Fiocco M; de Groot-Kruseman HA; van de Wetering MD; de Bont ES
    Eur J Cancer; 2016 Jan; 53():16-24. PubMed ID: 26700076
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bacteremia in hematological and oncological children with febrile neutropenia: experience in a tertiary medical center in Taiwan.
    Lai HP; Hsueh PR; Chen YC; Lee PI; Lu CY; Lu MY; Lin WC; Hsieh YC; Lee CY; Lin KH; Huang LM
    J Microbiol Immunol Infect; 2003 Sep; 36(3):197-202. PubMed ID: 14582565
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical parameters associated with low bacteremia risk in 1100 pediatric oncology patients with fever and neutropenia.
    Baorto EP; Aquino VM; Mullen CA; Buchanan GR; DeBaun MR
    Cancer; 2001 Aug; 92(4):909-13. PubMed ID: 11550165
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discontinuation of antimicrobial therapy for febrile, neutropenic children with cancer: a prospective study.
    Santolaya ME; Villarroel M; Avendaño LF; Cofré J
    Clin Infect Dis; 1997 Jul; 25(1):92-7. PubMed ID: 9243041
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predicting the risk of bacteremia in childen with fever and neutropenia.
    Rackoff WR; Gonin R; Robinson C; Kreissman SG; Breitfeld PB
    J Clin Oncol; 1996 Mar; 14(3):919-24. PubMed ID: 8622040
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical characteristics and outcomes of Pseudomonas aeruginosa bacteremia in febrile neutropenic children and adolescents with the impact of antibiotic resistance: a retrospective study.
    Kim HS; Park BK; Kim SK; Han SB; Lee JW; Lee DG; Chung NG; Cho B; Jeong DC; Kang JH
    BMC Infect Dis; 2017 Jul; 17(1):500. PubMed ID: 28716109
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multisite external validation of a risk prediction model for the diagnosis of blood stream infections in febrile pediatric oncology patients without severe neutropenia.
    Esbenshade AJ; Zhao Z; Aftandilian C; Saab R; Wattier RL; Beauchemin M; Miller TP; Wilkes JJ; Kelly MJ; Fernbach A; Jeng M; Schwartz CL; Dvorak CC; Shyr Y; Moons KGM; Sulis ML; Friedman DL
    Cancer; 2017 Oct; 123(19):3781-3790. PubMed ID: 28542918
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Implementation of risk stratified antibiotic therapy for neutropenic fever: what are the risks?
    Wierema J; Konecny P; Links M
    Intern Med J; 2013 Oct; 43(10):1116-24. PubMed ID: 23869563
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Value of electronic data for model validation and refinement: bacteremia risk in children with fever and neutropenia.
    Madsen K; Rosenman M; Hui S; Breitfeld PP
    J Pediatr Hematol Oncol; 2002 May; 24(4):256-62. PubMed ID: 11972092
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Short courses of intravenous empirical antibiotic treatment in selected febrile neutropenic children with cancer.
    Lehrnbecher T; Stanescu A; Kühl J
    Infection; 2002 Jan; 30(1):17-21. PubMed ID: 11876510
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A simple clinical decision rule may help to rule out severe bacterial infection and spare antibiotics in febrile young children.
    Feildel-Fournial C; Danjou L; Hubert-Dibon G; Vrignaud B; Masson D; Launay E; Guen CG
    Acta Paediatr; 2023 Apr; 112(4):837-845. PubMed ID: 36719186
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Randomized comparison of cefepime versus ceftazidime monotherapy for fever and neutropenia in children with solid tumors.
    Kebudi R; Görgün O; Ayan I; Gürler N; Akici F; Töreci K
    Med Pediatr Oncol; 2001 Apr; 36(4):434-41. PubMed ID: 11260566
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Febrile neutropenia: a prospective study to validate the Multinational Association of Supportive Care of Cancer (MASCC) risk-index score.
    Uys A; Rapoport BL; Anderson R
    Support Care Cancer; 2004 Aug; 12(8):555-60. PubMed ID: 15197637
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral antibiotics with early hospital discharge compared with in-patient intravenous antibiotics for low-risk febrile neutropenia in patients with cancer: a prospective randomised controlled single centre study.
    Innes HE; Smith DB; O'Reilly SM; Clark PI; Kelly V; Marshall E
    Br J Cancer; 2003 Jul; 89(1):43-9. PubMed ID: 12838298
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antimicrobial prophylaxis and outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology clinical practice guideline.
    Flowers CR; Seidenfeld J; Bow EJ; Karten C; Gleason C; Hawley DK; Kuderer NM; Langston AA; Marr KA; Rolston KV; Ramsey SD
    J Clin Oncol; 2013 Feb; 31(6):794-810. PubMed ID: 23319691
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ciprofloxacin and amoxicillin as continuation treatment of febrile neutropenia in pediatric cancer patients.
    Park JR; Coughlin J; Hawkins D; Friedman DL; Burns JL; Pendergrass T
    Med Pediatr Oncol; 2003 Feb; 40(2):93-8. PubMed ID: 12461792
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Febrile neutropenia in children with cancer in a medical center of Santiago, Chile].
    Arnello L M; Quintana B JA; Barraza C P
    Rev Chilena Infectol; 2007 Feb; 24(1):27-32. PubMed ID: 17369967
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.